These results suggest that VEGF produced primarily by recipient-derived tumor stromal cells, presumably TAM, rather than transplanted tumor cells, is involved in enhancing angiogenesis in high PTH-expressing tumors. This evidence concerns the gene VEGFA and neoplasm.